CD8A and neoplasm: With the proportion of proliferating CD8+ T cells on day 4 after tumor IR of 9.44 ± 1.37% compared to 4.55 ± 1.12% in the “Sham IR + ICI” group, the magnitude of the increase was comparable to the of the “TM + NEO-DLN IR + ICI” group (8.13 ± 2.14%).